Reply to 'New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination'.

Autor: Magnaterra E; Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy., Mariotti EB; Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy., Corrà A; Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy., Aimo C; Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy., Quintarelli L; Rare Diseases Unit, Section of Dermatology, Department of Health Sciences, Azienda USL Toscana Centro, European Reference Network-Skin Member, University of Florence, Florence, Italy., Ruffo di Calabria V; Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy., Verdelli A; Rare Diseases Unit, Section of Dermatology, Department of Health Sciences, Azienda USL Toscana Centro, European Reference Network-Skin Member, University of Florence, Florence, Italy., Caproni M; Rare Diseases Unit, Section of Dermatology, Department of Health Sciences, Azienda USL Toscana Centro, European Reference Network-Skin Member, University of Florence, Florence, Italy.
Jazyk: angličtina
Zdroj: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 May; Vol. 38 (5), pp. e366-e367. Date of Electronic Publication: 2023 Dec 08.
DOI: 10.1111/jdv.19693
Databáze: MEDLINE